Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study

Sensorion reports further analysis from its Proof of Concept Phase 2a clinical trial of SENS-401 for residual hearing preservation in adult patients following cochlear implantation.